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Conjugation of CS Oligosaccharides to 1,2-(Bisaminooxy)ethane for Microarray Production 
Ozonolysis of the anomeric allyl group and linkage of CS compounds 1-41,2 to 1,2-
(bisaminooxy)ethane3 proceeded as follows: oligosaccharide (0.51 µmol) was dissolved in MeOH (500 µL) 
and cooled to –78 °C. O3 was bubbled through the reaction until a blue color persisted (1 min). The reaction 
was then purged with N2 until colorless, quenched with Ph3P beads (3 mg), and gradually warmed to rt over 
12 h. It was filtered and the product concentrated to afford the desired aldehyde as a white solid. The 
aldehyde (0.51 µmol) was then reacted for 14 h at rt with 1,2-(bisaminooxy)ethane hydrochloride (1.4 mg, 
15 µmol) that had been dissolved in H2O (100 µL) and pH adjusted to 5.0 with 1 M NaOH. The resulting 
oxime product was purified using a SepPak C18 column (500 mg, H2O) and Sephadex G-10 (CS-E 
disaccharide, H2O) or Sephadex G-25 (tetrasaccharides, H2O) to afford a white solid in quantitative yield 
(0.51 µmol). CS-A aminooxy: ESI MS: m/z: calcd for C32H48N4Na3O31S2: 1117.1; found 1117.0. CS-C 
aminooxy: ESI MS: m/z: calcd for C32H48N4Na3O31S2: 1117.1; found 1117.0. CS-E aminooxy: ESI MS: 
m/z: calcd for C32H46N4Na5O37S4: 1321.0; found 1321.0. CS-E di amminooxy: ESI MS: m/z: calcd for 
C18H28N3Na2O20S2: 716.1; found 716.0. Mass spectra were obtained on a PerkinElmer/Sciex API 365 triple 
quadrupole/electrospray tandem mass spectrometer in the Protein/Peptide MicroAnalytical Laboratory at 
the California Institute of Technology. 
 The relative concentrations of the aminooxy oligosaccharides were calibrated to one another using 
the carbazole assay for uronic acid residues.4 Briefly, the acid borate reagent (1.5 mL of 0.80 g sodium 
tetraborate, 16.6 mL H2O, and 83.3 mL H2SO4) was added to 20-mL glass vials with Teflon caps. The 
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aminooxy oligosaccharides (50 µL of a 0.2 mg/mL stock in H2O) were added and the solution placed in a 
boiling H2O bath for 10 min. Following addition of the carbazole reagent (50 µL of 0.1% w/v carbazole in 
100% EtOH), the solution was boiled for 15 min. The absorbance was read at 530 nm and compared to a D-
glucuronolactone standard in H2O. 
 
Carbohydrate Microarrays 
Solutions of the aminooxy oligosaccharides (in 300 mM NaH2PO4, pH 5.0, 10 µL/well in a 384-
well plate) were arrayed on Hydrogel Aldehyde slides (NoAb Biodiscoveries) by using a Microgrid II 
arrayer (Biorobotics) to deliver sub-nanoliter volumes at rt and 50% humidity.  Concentrations of 
carbohydrates ranged from 0 – 500 µM.  The resulting arrays were incubated in a 70% humidity chamber at 
rt for 12 h and then stored in a low humidity, dust-free dessicator.  The pH and reaction time were 
optimized to provide maximum immobilization of the compound.   A pH screen with values between 4.0 
and 9.0 (0.5 unit increments) showed that pH 5.0 yielded maximal binding to the slide and a time screen 
with values between 0 and 16 hours (4 h increments) showed that 12 h provided maximal immobilization.  
Non-specific attachment of CS oligosaccharides lacking the aminooxy linker (e.g., compounds 1-4) was not 
observed.  Prior to use, the arrays were outlined with a hydrophobic pen (Super Pap Pen, Research Products 
International) to create a boundary for the protein treatments and rinsed three times with H2O.  The slides 
were then blocked by treatment with NaBH4 (125 mg) in 140 mM NaCl, 2.7 mM KCl, 5.4 mM Na2HPO4, 
and 1.8 mM KH2PO4 (phosphate buffered saline, PBS, 50 mL) at rt for 5 min with gentle rocking and 
washed five times for 3 min with PBS.  For all incubations, the slides were placed in a covered pipette tip 
box.  Human TNF-α (Peprotech), FGF-1 (R&D Systems; both reconstituted to 2 µM in 0.1% Triton X-100 
in PBS), cell culture supernatant containing monoclonal anti-CS-A antibody, or cell culture supernatant 
containing monoclonal anti-CS-E antibody (both 1:1 in 0.1% Triton X-100 in PBS) were spotted onto the 
slides in 250 µL quantities, and incubated statically at rt for 2 h.  The slides were then washed as previously 
described and incubated with the appropriate primary antibody [anti-TNF-α (Peprotech) or anti-FGF-1 
(R&D Systems); 1:1000 in 0.1% Triton X-100 in PBS] for 2 h at rt with gentle rocking.  Following the 
incubation, the slides were washed as previously described and treated in the dark at rt with a secondary 
IgG antibody conjugated to Cy3 (Amersham; 1:5000 in 0.1% Triton X-100 in PBS) at rt for 1 h with gentle 
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rocking.  The slides were washed three times for 2 min with PBS, two times for 1 min with H2O, and dried 
under a gentle stream of N2.  Microarrays were analyzed at 532 nm using a GenePix 5000a scanner, and 
fluorescence quantification was performed using GenePix 6.0 software after correction for local 
background.  Each protein was analyzed in triplicate, and the data represent an average of at least five spots 
for a given carbohydrate concentration (Supporting Figure 1). All solutions used for the carbohydrate 
microarrays were sterile-filtered through a 0.2 µm syringe filter prior to use. 
 
CS-A and CS-E Antibody Development 
Balb/c mice were immunized with CS-A and CS-E tetrasaccharides conjugated to keyhole limpet 
hemocyanin (KLH), and sera and cell culture supernatants were tested for antibodies via ELISA and dot 
blot analysis.  Ozonolysis of the anomeric allyl group of the tetrasaccharide (0.51 µmol) as previously 
described was followed by treatment with KLH (0.44 mg, 0.0063 µmol) and NaCNBH3 (0.5 mg) in H2O 
(pH’d with 5% K2CO3 to pH 9.5) for 2 d at rt.  The product was then exhaustively dialyzed against 0.01 M 
Na2HPO4, 0.15 M NaCl, pH 7.4 at 4 °C and the protein concentration determined by BCA assay (Pierce). 
The epitope density was determined by comparing the conjugated proteins to the unconjugated proteins 
using the Habeeb assay.5  In short, to the protein solution (10 µL) in PBS (40 µL) were added 0.1% 
trinitrobenzenesulfonic acid (50 µL) and 4% NaHCO3, pH 9.5 (50 µL).  The mixture was incubated at 40 
°C for 2 h, quenched with 10% SDS (50 µL), 1 M HCl (25 µL), and H2O (500 µL), and the absorbance at 
363 nm was measured. The epitope densities were as follows: CS-A conjugate = 15 and CS-E conjugate = 
14. 
Three Balb/c female mice, 4-6 weeks old, were primed and boosted at 2-week intervals for a total of 
5 intraperitoneal injections (5 µg per injection).  CS-A- or CS-E-KLH conjugates were mixed with RIBI 
adjuvant (RIBI Immunochem) for the first two injections, and a final series of 3 boosts was performed 
without adjuvant.  Bleeds were taken 1 week after each injection and monitored by dot blot analysis.  The 
most responsive mouse was boosted and sacrificed after three days.  Spleen cells were fused with HL-1 
murine myeloma cells (Ventrex) using polyethylene glycol (PEG 1500, Boehringer-Mannheim) as 
described previously by Lebron et al.6  Multiclonal and monoclonal cell lines were then screened via 
ELISA analysis. 
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Antibody ELISA Analysis 
 CS tetrasaccharides 1-3 were conjugated to bovine serum albumin (BSA) as follows. Ozonolysis 
of the anomeric allyl group of the CS-A, -C, and -E tetrasaccharides (0.51 µmol) as described above was 
followed by treatment of each compound with BSA (0.34 mg, 0.0051 µmol) and NaCNBH3 (0.5 mg) in 
H2O (pH 9.5 using K2CO3) for 2 d at rt. The CS-BSA conjugates were then exhaustively dialyzed against 
0.01 M Na2HPO4, 0.15 M NaCl, pH 7.4 at 4 °C, and the protein concentrations were determined using the 
BCA assay (Pierce). The epitope densities were measured by comparing the conjugated proteins to the 
unconjugated proteins using the Habeeb assay. The epitope densities were as follows: CS-A conjugate = 
14, CS-C conjugate = 16, CS-E conjugate = 14. 
The BSA conjugates (1 µg/mL in 50 mM Na2CO3, pH 9.6) were added to a 384-well NUNC 
Maxisorp clear plate (25 µL per well), and the plate was sealed and incubated for 12 h at 4 °C.  The wells 
were aspirated, washed four times with PBS containing 0.05% Tween-20 (PBST, 75 µL/wash), and 
blocked for 2 h at rt with 10% horse serum (Gibco) in PBS (75 µL).  After the blocking step, the plate was 
washed four times with PBST, and the supernatants from the monoclonal anti-CS-A or CS-E antibody 
producing cultures (25 µL) were added to the wells and incubated at rt for 2 h.  Following aspiration, the 
wells were washed four times with PBST and treated with a horseradish peroxidase (HRP)-conjugated goat 
anti-mouse antibody (Pierce; 1:10,000, 25 µL/well) in blocking buffer for 1 h at rt.  The wells were again 
aspirated, washed four times with PBST, and then developed with ABTS liquid substrate solution (Sigma; 
25 µL/well, solution at rt) for 30 min at rt.  Color development was monitored on a Victor plate reader 
(PerkinElmer) at 405 nm.  Only clones specific for the CS-A or CS-E tetrasaccharides and with absorbance 
values greater than 1.0 were kept for subsequent dot blot screening. 
 
Dot Blot Analysis 
Immunoblotting analysis was performed by spotting solutions of the BSA conjugates (relative 
epitope density adjusted, 1-100 ng, 1 µL/spot) in 10 mM Tris•HCl, 0.02% Nonidet P-40, pH 7.5 onto 0.45 
µm nitrocellulose, allowing the spots to air dry, and fixing the blots with 40% MeOH, 10% AcOH, 50% 
S5 
H2O for 15 min at rt with gentle rocking. The dot blots were then blocked for 30 min in 5% non-fat milk 
containing 50 mM Tris•HCl pH 7.4, 150 mM NaCl, 0.05% Tween-20 (TBST) followed by treatment with 
the monoclonal antibody producing cell culture supernatant in blocking buffer (1:1) for 2 h at rt with gentle 
rocking. The blots were then washed with TBST three times for 10 min and treated with a horseradish 
peroxidase (HRP)-conjugated goat anti-mouse antibody (Pierce; 1:10,000) in blocking buffer for 1 h at rt 
with gentle rocking. The dot blots were washed with TBST three times for 10 min and visualized by 
chemiluminescence (SuperSignal West Pico, Pierce). Consistent with the microarray data, highly selective 
binding of the antibodies to their respective sulfated antigens was observed, and weak binding of the CS-E 
antibody to the CS-C motif was noted at very high concentrations. 
 
TNF-α  ELISA Analysis 
 Human recombinant TNFR1 (Peprotech; 1 µg/mL in 50 mM Na2CO3, pH 9.6) was added to a 384-
well NUNC Maxisorp clear plate (25 µL per well), and the plate was sealed and incubated for 12 h at 4 °C. 
The wells were aspirated, washed four times with PBS containing 0.05% Tween-20 (PBST, 75 µL/wash), 
and blocked for 2 h at rt with 1% BSA in PBS (75 µL). During this time, biotinylated TNF-α (PerkinElmer; 
25 µL/well of a 1 nM solution in 0.05% Tween-20, 0.1% BSA in PBS) was pre-incubated with the 
indicated concentrations of polysaccharides enriched in the CS-A, CS-C, or CS-E motifs (Seikagaku; 0.1 – 
100 µM in H2O) or CS-E tetrasaccharide 3 (0.01 – 5 mM in H2O). After the blocking step, the plate was 
washed four times with PBST, and the solutions of CS and TNF-α were added to the wells and incubated at 
rt for 2 h. Following aspiration, the wells were washed four times with PBST and treated with streptavidin-
HRP (Pierce; 25 µL/well, 1:2000 in 0.05% Tween-20, 0.1% BSA in PBS) for 30 min at rt. The wells were 
again aspirated, washed four times with PBST, and then developed with ABTS liquid substrate solution 
(Sigma; 25 µL/well, solution at rt) for 30 min at rt. Color development was monitored on a Victor plate 
reader (PerkinElmer) at 405 nm. Each carbohydrate concentration was analyzed in triplicate, and the 
absorbance values were corrected for background in the absence of carbohydrate and normalized with 
respect to the absorbance value at the lowest carbohydrate concentration. 
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Caspase Assay 
 U937 cells (ATCC) sensitive to TNF-α-induced apoptosis7 were cultured in RPMI 1640 medium 
containing 10% fetal bovine serum at 37 °C and 5% CO2/O2.  Cells were grown in every other well of a 
384-well NUNC sterile, clear plate (25,000 cells/well, 25 µL/well) for 18 h.  Solutions of the carbohydrates 
at the indicated concentrations (0.01 – 4000 µM in sterile PBS) were pre-incubated with TNF-α (1 µL/well 
of a 125 ng/mL solution in sterile PBS) at rt.  After 2h, the solutions were added to the cells and incubated 
for 18 h. At this time, caspase 3/7 activity was analyzed as described by Shi et al.8 using the Apo-One 
homogeneous caspase 3/7 assay kit (Promega) according to the manufacturer’s protocol. Readings were 
taken every 30 min for 18 h at rt on a Victor plate reader. By this time, caspase 3/7 activity had reached a 
plateau, and the endpoints of the various treatments were used for data analysis. Endpoint fluorescence 
values for controls containing only cells were subtracted from the experimental endpoint values, and the 
resulting values were then normalized with respect to that of the lowest carbohydrate concentration. Each 
carbohydrate concentration was repeated in triplicate. The CS-E tetrasaccharide and polysaccharide had no 
effect on the extent of apoptosis in the absence of TNF-α. 
S7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supporting Figure 1. CS microarrays for the analysis of glycosaminoglycan-protein interactions.  
Each microarray contained 1500 spots.  Representative portion of the microarrays, illustrating spot 
morphology and fluorescence intensity after incubation with (A) CS-A antibody and (B) CS-E antibody. 
(C) Higher magnification of a representative portion of the CS microarray after incubation with the CS-E 
antibody. The panels on the right indicate the corresponding oligosaccharides and their concentrations for 
each spot shown. Values are in µM. A = CS-A tetrasaccharide, C = CS-C tetrasaccharide, Di = CS-E 
disaccharide, E = CS-E tetrasaccharide. 
C 
B 
 90A     400A   2.5C     12.5E    17.5E     30E      60E     100E     Blank 
Blank    90A    400A     2.5C     12.5E    17.5E    30E      60E      100E 
 40A    Blank    90A     400A     2.5C     12.5E   17.5E    30E        60E 
100E     40A    Blank     90A     400A     2.5C    12.5E    17.5E     30E 
 60E     100E     40A     Blank    90A      400A    2.5C     12.5E    17.5E 
 30E      60E    100E      40A     Blank     90A     400A     2.5C     12.5E 
17.5E    30E      60E     100E     40A      Blank     90A     400A      2.5C 
12.5E   17.5E    30E      60E     100E       40A    Blank     90A      400A 
 2.5C    12.5E   17.5E    30E      60E       100E     40A     Blank      90A 
400A     2.5C    12.5E   17.5E    30E       60E      100E     40A      Blank 
 
 
A 
 25E      5A       15A       25A    50A     70Di      200Di     0E      75E      12.5Di 
12.5Di  22.5E     5A       15A    25A      50A       70Di    200Di    0E        7.5E 
 7.5 E  12.5Di   22.5E     5A      15A      25A       50A     70Di    200Di     0E 
  0E      7.5E     12.5Di   22.5E    5A      15A        25A     50A     70Di     200Di 
200Di    0E        7.5E    12.5Di  22.5E     5A        15A     25A     50A       70Di 
 70Di   200Di     0E        7.5E   12.5Di   22.5E      5A      15A     25A       50A 
 50A     70Di    200Di     0E       7.5E     12.5Di   22.5E     5A     15A       25A 
 25A     50A      70Di    200Di     0E       7.5E     12.5Di   22.5E    5A       15A 
 15A     25A      50A      70Di    200Di     0E        7.5E    12.5Di   22.5E     5A 
  5A      15A      25A       50A     70Di    200Di     0E       7.5E    12.5Di   22.5E 
 
 
60E       100E      40A 
 
 
30E       60E       100E 
 
 
17.5E    30E        60E 
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Supporting Figure 2. CS microarrays for the analysis of glycosaminoglycan-protein interactions.  
Each microarray contained 1500 spots.  Representative portion of the microarrays, illustrating spot 
morphology and fluorescence intensity after incubation with (A) TNF-α  and (B) the negative control, FGF-
1. The panels on the right indicate the corresponding oligosaccharides and their concentrations for each 
spot shown. Values are in µM. A = CS-A tetrasaccharide, C = CS-C tetrasaccharide, Di = CS-E 
disaccharide, E = CS-E tetrasaccharide. 
A 
B 
60A    100A    500A      50C      10E      20E       35E     70E     25Di 
50Di     60A     100A    500A    50C       10E       20E     35E      70E 
25Di    50Di     60A     100A    500A     50C       10E     20E      35E 
70E     25Di     50Di     60A     100A    500A     50C      10E      20E 
35E     70E      25Di     50Di     60A      100A   500A     50C      10E 
20E     35E       70E     25Di     50Di      60A    100A    500A     50C 
10E     20E       35E      70E     25Di      50Di     60A    100A     500A 
50C     10E        20E     35E      70E       25Di     50Di    60A     100A 
500A    50C       10E     20E      35E       70E      25Di    50Di     60A 
  
 
 
60A    100A    500A      50C      10E      20E       35E     70E     25Di 
50Di     60A     100A    500A    50C       10E       20E     35E      70E 
25Di    50Di     60A     100A    500A     50C       10E     20E      35E 
70E     25Di     50Di     60A     100A    500A     50C      10E      20E 
35E     70E      25Di     50Di     60A      100A   500A     50C      10E 
20E     35E       70E     25Di     50Di      60A    100A    500A     50C 
10E     20E       35E      70E     25Di      50Di     60A    100A     500A 
50C     10E        20E     35E      70E       25Di     50Di    60A     100A 
500A    50C       10E     20E      35E       70E      25Di    50Di     60A 
  
 
 
A B
C D
E
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